BERLIN—Bayer AG on Tuesday disclosed another jump in the number of lawsuits alleging the German company’s recently acquired weedkillers cause cancer in a sign that an issue that has wiped billions off Bayer’s market valuation isn’t fading away. Lawsuits from 9,300 plaintiffs were pending at the end of October, compared with 8,700 at the end of August, Bayer said. Plaintiffs claim that Roundup weedkillers, which Bayer acquired in its takeover of Monsanto Co., made them ill and that Monsanto knew or should have known of the...
lawsuits accusing Bayer of Roundup of causing cancer have increased from 8,700 in August to 9,300 in October . Bayer took ownership of the weedkiller as part of its acquisition of Monsanto . Plaintiffs claim Monsanto either knew , or should have known , the manufacturer of the product . they argued that manufacturers and regulators have said the weedkiller 's compound is safe . Bayer has invested € ##500 ( $ 33.9bn ) in market capitalisation since August , when a US jury ruled the company liable for a former groundskeeper 's terminal non - Hodgkin drug . The company has since launched an appeal against the decision .